Once you start taking a GLP-1, you likely will have to be on it for a very long time (maybe forever) to maintain results, although the dosage may be much lower
In the phase 2 clinical trial, 3-26% of patients who used retatrutide experienced vomiting, compared to 1% in the placebo group
"When hunger is reduced, people finally feel able to follow the healthy steps they were told to take for years. Globally, more than 1 billion people currently live with obesity, a number projected to reach 2 billion by 2030
Most patients self-administer their weekly injections at home after completing in-office training
If you miss by more than 3 days, skip that week and take the next scheduled dose
UV exposure and elevated temperatures accelerate peptide breakdown